Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Venous ulcer Stories

2012-12-22 05:03:42

Specializing in improving the quality of life for those suffering from venous and lymphatic diseases, BSN Medical develops and manufactures products used in the care and management of afflictions like varicose veins, chronic venous insufficiency, deep vein thrombosis, venous ulcers, peripheral edemas and lymphodema. As the number one physician-recommended brand of compression hosiery in the USA, the JOBST® brand from BSN Medical sets the standard for quality and is recognized and...

2012-12-17 08:25:12

NESS ZIONA, Israel, December 17, 2012 /PRNewswire/ -- CollPlant (TASE:CLPT) designer and manufacturer of medical products based on a recombinant protein sourced from tobacco plants, announced today that it received CE mark approval for European sale and marketing of its Vergenix(R)WD product, a company-developed wound healing product. Vergenix(R)WD is based on CollPlant's recombinant human collagen to treat patients with lower limb ulcer. Yehiel Tal, CollPlant's CEO:...

2012-12-12 05:04:18

Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine discusses ways to promote healthy legs this holiday season. South Portland, ME (PRWEB) December 11, 2012 Approximately half of the U.S. population has some form of venous disease, which includes (but is not limited to) varicose veins. According to Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine, there´s plenty one can do to alleviate the symptoms of vein disease and prevent them from getting worse. “Venous...

2012-10-25 04:00:27

Vein specialist Dr. Cindy Asbjornsen of the Vein Healthcare Center in Maine discusses the causes and treatments of spider veins. South Portland, ME (PRWEB) October 24, 2012 Telangiectasia is the technical term, but most people know them as “spider veins.” The tiny red-, blue- or purple-colored veins occur just below the skin but are close enough to be seen on the surface. They may appear as short fine lines, clusters, or in a spider web shape. According to Dr. Cindy Asbjornsen...

2012-09-11 02:29:18

FORT WORTH, Texas, Sept. 11, 2012 /PRNewswire/ -- Healthpoint Biotherapeutics today announced the initiation of a Phase III clinical trial investigating the efficacy of HP802-247 for the treatment of venous leg ulcers. HP802-247 is an investigational allogeneic living cell bioformulation containing keratinocytes and fibroblasts. The study is designed to evaluate complete wound closure in subjects receiving HP802-247 plus compression therapy compared to those receiving vehicle control plus...

2012-08-07 06:26:02

KENNESAW, Ga., Aug. 7, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has closed a clinical trial involving its EpiFix® dehydrated human amniotic membrane allograft for the treatment of diabetic neurovascular foot ulcers. This prospective trial design initially targeted 80 patients. Those patients...

Cell-Based Therapy Helps Leg Ulcers Heal In The Form Of Spray-On Skin
2012-08-03 08:47:53

Lawrence LeBlond for redOrbit.com - Your Universe Online A topical spray containing a unique formula of living human cells developed and studied by US and Canadian researchers has been shown to provide a 52 percent greater chance of healing chronic venous leg ulcers than treatment with compression bandages alone. Findings of the study are published in the latest issue of the journal The Lancet. Leg ulcers, painful open wounds that can last for months without proper treatment, are...

2012-08-02 14:22:16

FORT WORTH, Texas, Aug. 2, 2012 /PRNewswire/ -- Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue. HP802-247 is an investigational allogeneic living cell bioformulation containing keratinocytes and fibroblasts currently under development for the...

2012-07-25 02:31:19

FORT WORTH, Texas, July 25, 2012 /PRNewswire/ -- Healthpoint Biotherapeutics today announced that the results of a 24-week open-label follow-up to the HP802-247 Phase 2b trial will be presented by Robert Kirsner, MD, PhD, on Friday, July 27, 2012, from 3:55-4:15 pm, during the American College of Wound Healing and Tissue Repair held at the Swissotel in Chicago. HP802-247 is an allogeneic living cell bioformulation containing keratinocytes and fibroblasts currently being investigated for the...

2012-07-17 02:27:20

CHANDLER, Ariz., July 17, 2012 /PRNewswire/ -- Vomaris Innovations, Inc., a leading regenerative medicine company focusing on wound care with bioelectric technology, has been granted another patent (U.S. Pat. No. 8,224,439) related to its bioelectric technology surrounding the use of devices that rely upon reducing and oxidizing agents to treat biologic tissue and promote healing. "Our growing and valuable patent estate is indicative of the powerful momentum behind our leading bioelectric...